CINECA IRIS Institutional Research Information System

A multicenter, randomized phase III study of second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients who progressed to a first-line treatment containing bv: results from the bebyp trial by the Gruppo Oncologico Nord Ovest (GONO).

SALVATORE L;MASI G;LOUPAKIS F;CREMOLINI, CHIARA;SCHIRRIPA M;FORNARO L;ANTONIOTTI C;VIVALDI C;GRANETTO C;FEA E;ANTONUZZO L;GIOMMONI E;BONI C;BANZI M;CHIARA S;SONAGLIO C;ALLEGRINI G;MARCUCCI L;VALSUANI C;GRECO F;SAFINA V;BONI L;FALCONE, ALFREDO

2012-01-01